Navigation Links
Glivec Enhances Survival Rates In Leukemia

Glivec, a drug used to treat chronic myeloid leukemia has shown to improve the survival rates in 90 percent of patients with the cancer.// The National Institute for health and Clinical Excellence (NICE), which regulates drug approvals in the UK had only wanted to approve Glivec for advanced cases, but the drug has not proved itself in clinical trials.

CML is a common form of blood cancer, which arises due to a defect in the production of white blood cells. Glivec targets only the affected molecules and leaves the healthy ones unaffected. But it is an expensive drug and costs at least ￡14,000 per patient per year.

Results from the IRIS study showed that 93 percent of patients taking the drug in early stages did not progress to advanced stage. Also 83 percent had good survival rate of five years. Before the introduction of Glivec, CML had poor prognosis with survival rates of only four to six years.

Sandy Craine, from CML Support, who took part in the trial said, "I never would have believed I would be standing here today. Glivec helped save my life and I am grateful that I can pass on this message of hope to others diagnosed with this once devastating disease."

Professor Charles Craddock, director of Stem Cell Transplant Unit, Queen Elizabeth Hospital, Birmingham, added, "The significant success of Glivec in treating CML is an exciting model for the development of new treatments for other cancers."
'"/>




Page: 1

Related medicine news :

1. Glivec - New Hope For CMC Patients
2. Glivec the hot cancer drug from Novartis
3. Animal Fat Enhances Risk Of Stomach
4. Tiagabine Enhances Sleep Maintenance In Insomnia Patients
5. Simulated Heart Tissue Enhances Understanding of Arrhythmias And Defibrillator Failure
6. Study Claims That Chemo Before And After Surgery Enhances Survival Rates
7. Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs
8. Haryana Enhances Nutritional Support for Women, Children
9. Loop Incision Treatment Enhances Premature Delivery Risk
10. Long-Term Survival can be Predicted by a Simple Lung Test
11. Hepatitis G May Boost HIV Survival
Post Your Comments:
(Date:12/5/2009)... Wind Turbines are popping ...g from growing mushrooms, making wine to keeping p...B) December 5, 2009 -- Who would have thought that...rom Wind Turbines? Wind Inc. of Fort Worth, Texas ... end users, not wind farms. "Using a technology d...
(Date:12/4/2009)... , PEMBROKE, Bermuda, Dec. 4 Allied World ...ay announced that Scott Carmilani,President and Ch... Vice,President and Chief Corporate Strategy Offic....S. Financial Services Conference being held at th... on Tuesday, December 8, 2009. ,, About Allied...
(Date:12/4/2009)... , ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief...elected as a finalist for the "Chief Innovation Of...ness with the power of cloud computing. Appy Award...e usage of Salesforce CRM or the Force.com platfor...eir sales, marketing, partner, service, support or...
(Date:12/4/2009)...Working with mice, scientists at Johns Hopkins pub...shown that a protein made by a gene called "Twist"...y distinguish stem cells that drive aggressive, me...lls. , Building on recent work suggesting that it...east tumors that drives breast cancer, scientists ...
(Date:12/4/2009)...comes same whether procedure done immediately or 3... 4 (HealthDay News) -- Timing of surgical repair o...s may not affect patient outcome, a new study has ...om traumatic knee dislocations that can occur in h...ptimal time to perform surgery to repair these inj...
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
... AFL ) announced today that it will make a present...y-Fourth Annual Strategic Decisions Conference,200...loninger III will,represent Aflac Incorporated, an...ny,s outlook for 2008 and its strategy for,growth ...
...stopher Georgacas and Mark Mi...At its Board Meeting earlier today,the Board of Di...llion in,new grants to expand QUITPLAN(R) Services...ard also welcomed three new,Board Members, the Hon...
... allergy symptoms, PROVIDENCE, R.I., May 21 Apri......sneezes?, For those allergy sufferers out ther...the end of cold weather and snow is certainly welc... Month,and CleanBrands, creators of The World,s Cl...
...erations and new agr...TC,Bulletin Board: ISCR), a leading distributor of...ll, life-saving prescription drugs and a developer...t,highlights include:, -- Revenue grew by 258% i...
...reast Cancer Research Fund, WEST CHESTER, Pa., Ma...y when leading multimedia retailer QVC(R) once aga...7 at 1 AM (ET) and 6 PM,(ET). These two one-hour p...newscom.com/cgi-bin/prnh/20070923/NESU001LOGO ), ...
... played,host to nearly 300 guests at its PowerPlex...ent speaker who provided a poignant report on the ...newscom.com/cgi-bin/prnh/20070627/CLW071LOGO ), ...His remarks included the findings of a survey cond...
Other Medicine News:Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobacco's Harm 2Health News:ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobacco's Harm 3Health News:Spring Allergies Got You Down? Try Some of These Drug-Free Options 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:A Touch of Pink Never Looked So Good 2Health News:PowerPlex 2008 User Conference Features Manufacturing Survey by Leading Publication Managing Automation 2Health News:PowerPlex 2008 User Conference Features Manufacturing Survey by Leading Publication Managing Automation 3
(Date:12/3/2009)...WARRENDALE, Pa., Dec. 3 Radiology imaging leader ...ntegration capabilities at the November 2009 Radio...nnect.PACS(TM) product, enabling the first radiol...atest release in the company,s newly branded Cert...p://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
(Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, D...iR-122, a microRNA Important for,Hepatitis C Viral...itis C,Virus in the Bloodstream in Chimpanzees Chr... - SPC3649 Demonstrates Efficacy With No Evidence ...in the Treated Animals - Signaling a Potential,Ben...
(Date:12/3/2009)....C., Dec. 3 In response to the increasingly criti... the evolving healthcare delivery system, Duke Med...matics (DCHI) to provide a campus focus for health...rdisciplinary approach to education that will prod...lthcare administrators with an expertise in the us...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Drop in Certain Visual Skills May Precede Alzheimers 59310 1Drop in Certain Visual Skills May Precede Alzheimers 59310 2With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 1With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 2With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 3Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 1Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 2Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 3Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 4
...15 Pre-mixed insulin,analogues, a modified form o...ffective than long-acting analogues for controllin...with type 2 diabetes, according to a report,funded..., part of the U.S.,Department of Health and Human ...however, appears to be equally,effective as pre-mi...
.... 15 , -- Results inconclusive, as primary outcom...ther donepezil or AZD3480; results impacted by ...own on secondary outcome measures ADCS-CGIC and MM...mparable to placebo, with fewer GI-related AEs...alysis of full dataset and planned discussions...
Other Medicine Technology:Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 2Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 2AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 4
Teardrop punch, Left
Meniscus Screw
Biosteon™ (HA/PLLA) Wedge Interference Screws
Graft Workstation
Medicine Products: